Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


NeoStem's CEO Letter to Shareholders 

 

Our cell therapy manufacturing business is growing and client satisfaction confirms our belief and excitement that we have unique skills and people (expertise, quality and work ethic) to serve as a platform to be a global leader in the cell therapy ...Read More. ​

 

Posted on 15-Mar-12 by Geier, Eric
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: